Transcat, Inc. (TRNS) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Transcat, Inc. (TRNS) Industrial Operations Profile

Transcat, Inc. specializes in calibration and laboratory instrument services, offering a dual-segment business model that combines service and distribution, catering to highly regulated industries such as life sciences and aerospace.

What Is the Investment Thesis for TRNS?

The company’s P/E ratio of 222.59 reflects investor confidence, although it indicates high expectations for future growth. Key growth catalysts include the increasing demand for compliance and quality assurance in regulated industries, alongside the expansion of its proprietary software solutions like CalTrak. Furthermore, Transcat's strategic focus on value-added services enhances its competitive edge. However, potential risks include economic fluctuations affecting client budgets and competition within the calibration service market. Overall, the company’s operational efficiency and market adaptability position it well for sustained growth.

Based on FMP financials and quantitative analysis

TRNS Key Highlights

Market cap of $771M indicates a solid presence in the industrial distribution sector.

• P/E ratio of 222.59 suggests high growth expectations from investors.
• Profit margin of 2.6% reflects the company's operational efficiency in a competitive market.
• Gross margin of 32.5% exceeds many industry peers, indicating effective cost management.
• Stable employee base of 1,104 supports robust service delivery and operational capabilities.

Who Are TRNS's Competitors?

TRNS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are TRNS's Key Strengths?

Established brand with a long history in calibration services.

• Diverse revenue streams from both service and distribution segments.
• Strong customer base in highly regulated industries.

What Are TRNS's Weaknesses?

High P/E ratio may indicate overvaluation relative to earnings.

• Limited geographic presence compared to larger competitors.
• Dependence on regulatory compliance may impact growth.

What Could Drive TRNS Stock Higher?

Expansion of CalTrak software features to enhance customer experience.

• Increased demand for calibration services in life sciences due to regulatory changes.
• Strategic partnerships with key industry players to broaden service offerings.

What Are the Key Risks for TRNS?

Inconsistent delivery — missed Wall Street EPS estimates in 5 of the last 8 reported quarters.

• Rich valuation — a P/E of 222.59 runs well above the Industrials sector’s ~28.00x, leaving little room for a miss.
• Insider selling — insiders were net sellers of roughly $1.3M recently.
• Economic fluctuations impacting client spending on calibration services.
• Intense competition from other calibration service providers.
• Regulatory changes that could affect operational compliance.

What Are the Growth Opportunities for TRNS?

• Growth opportunity 1: The life sciences sector is projected to grow at a CAGR of 7.5% over the next five years, driven by increased regulatory scrutiny and the need for precise calibration services. Transcat's established reputation in this sector positions it to capture a larger market share through enhanced service offerings and technological advancements.
• Growth opportunity 2: The expansion of Transcat's proprietary software, CalTrak, is expected to enhance customer engagement and streamline operations. As industries increasingly adopt digital solutions, the market for asset management software is anticipated to grow significantly, providing Transcat with an opportunity to upsell and cross-sell services.
• Growth opportunity 3: The demand for calibration services in the aerospace and defense sectors is on the rise due to increased government spending and regulatory requirements. Transcat can leverage its expertise to expand its footprint in these markets, potentially increasing revenue from this segment by 15% over the next three years.
• Growth opportunity 4: The trend towards outsourcing calibration services is gaining momentum, with companies preferring to partner with specialized firms rather than maintaining in-house capabilities. This shift could lead to increased market penetration for Transcat, particularly among small to mid-sized enterprises looking for cost-effective solutions.
• Growth opportunity 5: The global market for test and measurement instruments is expected to reach $30 billion by 2028, growing at a CAGR of 5%. Transcat's distribution segment is well-positioned to capitalize on this growth, especially as industries seek reliable suppliers for high-quality instruments.

What Are TRNS's Competitive Advantages?

• Strong reputation for quality and reliability in calibration services.
• Proprietary software solutions that enhance customer engagement and operational efficiency.
• Established relationships with clients in highly regulated industries.
• Diverse service offerings that cater to multiple sectors, reducing dependency on any single market.

What Does TRNS Do?

Transcat, Inc. was founded in 1964 and has since evolved into a prominent player in the calibration and laboratory instrument services sector. Headquartered in Rochester, New York, the company operates through two primary segments: Service and Distribution. The Service segment provides a wide array of offerings, including calibration, repair, inspection, analytical qualification, and preventative maintenance. A key component of this segment is the proprietary CalTrak software, which streamlines the management of calibration workflows and customer assets. Additionally, the Compliance, Control and Cost portal enhances customer experience by offering web-based asset management capabilities. The Distribution segment focuses on selling and renting test, measurement, and control instruments, alongside value-added services such as equipment rental and certification. Transcat markets its products through various channels, including digital and print advertising, outbound sales efforts, and an inbound call center. The company primarily serves highly regulated industries, particularly life sciences, which encompasses pharmaceutical, biotechnology, and medical device sectors, as well as aerospace, defense, energy, and utilities. Transcat's commitment to accuracy and compliance positions it as a trusted partner for clients requiring precise instrumentation and calibration services.

What Products and Services Does TRNS Offer?

• Provide calibration and repair services for laboratory instruments.
• Offer proprietary software solutions for asset management and workflow integration.
• Sell and rent test, measurement, and control instruments.
• Deliver value-added services such as equipment certification and rental.
• Serve highly regulated industries including life sciences, aerospace, and defense.
• Market products through digital, print, and direct sales channels.

How Does TRNS Make Money?

• Generate revenue through service contracts for calibration and maintenance.
• Earn income from the sale and rental of test and measurement instruments.
• Provide consulting services to help clients comply with regulatory standards.
• Leverage proprietary software to enhance service delivery and customer engagement.

What Industry Does TRNS Operate In?

The industrial distribution industry is experiencing a shift towards increased automation and digitalization, particularly in calibration services. The market is expected to grow as regulations tighten across various sectors, particularly in life sciences, where precision and compliance are paramount. Transcat, Inc. is well-positioned within this landscape, leveraging its dual-segment model to meet diverse customer needs. The competitive landscape includes several established players, but Transcat's focus on high-quality service and proprietary technology gives it a distinct advantage.

Who Are TRNS's Key Customers?

• Pharmaceutical and biotechnology companies requiring precise calibration services.
• Medical device manufacturers focused on compliance with FDA regulations.
• Aerospace and defense contractors needing accurate measurement tools.
• Energy and utility companies requiring reliable test and measurement solutions.

Transcat, Inc. Financial Trajectory

Transcat, Inc. (TRNS) reported $92.9M in revenue for Q1 FY2027, reflecting 4.1% growth compared to the prior quarter. The company recorded net income of $1.3M, with diluted EPS of $0.14. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this small-cap Industrials company. Across the four most recent quarters, TRNS averaged $0.09 in diluted EPS.

Company Profile

Transcat, Inc. operates in the Specialty Business Services industry within the Industrials sector. It is headquartered in Rochester, US. The company is led by CEO Jaime A. Irick. TRNS has traded publicly since 1977.

How Transcat, Inc. Is Valued

Transcat, Inc. carries a market capitalization of $771M, placing it in the small-cap category. Analyst price targets span from $94.00 to $160.00, with a consensus of $123.60. At the current price of $82.36, that implies approximately 50% upside potential. Relative to its peer group, TRNS's quantitative score of 57/100 is roughly in line with the peer average of 67/100.

Return on equity for Transcat, Inc. stands at 1.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.7%, showing how much profit it generates from its asset base. TRNS trades at a trailing price-to-earnings ratio of 222.59, above the Industrials sector average of ~28.00x. Its free cash flow yield is 3.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.49 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 0.4%, the inverse of the P/E and a quick read on earnings relative to price.

Transcat, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 3.67 places it in the safe zone, indicating low near-term bankruptcy risk.

Transcat, Inc. has missed Wall Street's EPS estimate in 5 of its last 8 reported quarters — a mixed record worth weighing. Reported results have landed about 11.7% below estimates on average.

Over the past six months, Transcat, Inc. insiders filed 28 SEC Form 4 transactions — 12 sales and 16 purchases. On net that is roughly 14K shares acquired (about $1.3M) — insiders putting money in tends to read as conviction.

TRNS Financials

TRNS Latest News

TRNS Analyst Consensus

TRNS MoonshotScore

What Investors Ask About Transcat, Inc. (TRNS) — Industrials

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources